Etf Prime Logo

Welcome to the ETF Prime Podcast

One of the “most helpful plain-English resources for investors who want to demystify exchange-traded funds” – Bloomberg Businessweek

Latest Episode​

Anthropic IPO & Bitcoin DRIP ETFs

Roxanna Islam, Head of Sector & Industry Research at VettaFi, discusses the upcoming Anthropic IPO and how investors can gain exposure today through ETFs, including those using swaps tied to perpetual futures contracts. Todd Mathias, Head of U.S. ETF Product Strategy & Development at Franklin Templeton, goes inside the firm’s expanding ETF lineup, from its recently launched Bitcoin DRIP ETFs to its active fixed income offerings.

About the Podcast

ETF Prime is hosted by Nate Geraci. Learn how to make ETFs a part of your investment portfolio as Nate spotlights individual ETFs and interviews experts from across the country. ETF Prime is available on Apple Podcasts, Android, Spotify, and most other major podcasting platforms. Specific guest interviews can be accessed by visiting the ETF Expert Corner.

Nate Geraci Headshot

Recent Episodes

Proposed Bitcoin & Marijuana ETFs Generate Intrigue, Controversy

Two proposed ETFs, the Winklevoss Bitcoin Trust and the Emerging AgroSphere ETF, are currently in registration with the Securities & Exchange Commission.  Nate and Jason explain the backstories behind these ETFs and offer some perspective on their potential investment merit.  Maz Jadallah, CEO & Founder of AlphaClone, spotlights the AlphaClone International ETF and discusses the concept of “active indexing”.

Biotech Expert Brad Loncar Discusses Sector, ETFs

Biotech industry expert Brad Loncar discusses his approach to investing in biotech stocks and key current drivers in the sector.  Brad also offers his perspective on broad-based biotech ETFs and explains the index behind the Loncar Cancer Immunotherapy ETF (CNCR).  Nate & Jason spotlight the First Trust NYSE Arca Biotechnology Index Fund (FBT).

Vanguard’s Rich Powers Talks Low Cost ETFs, ETF Growth

Rich Powers, Head of ETF Product Management at Vanguard, explains Vanguard’s low cost positioning in ETFs, offers his perspective on ETF growth, and spotlights two popular Vanguard ETFs. Also, Nate & Conor discuss the latest surrounding the DOL fiduciary rule and its impact on ETFs.

Skip to content